MedTrace Logo

Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection

NCT04362956 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2025-03-12

No results posted yet for this study

Summary

This is a multi-center prospective study that aims to investigate the clinical and immunologic impact of SARS-CoV-2 infection in pregnant women and neonates. The goal is to recruit 200 SARS-CoV-2 infected pregnant women starting at 24 weeks of gestation in a neonatal network of 45.000 birth a year. Clinical data will be collected from women and neonates. Upper airways samples will be obtained from both for bio-markers investigation. Finally, maternal and umbilical cord serum and human milk will be obtained for antibody assessment.

Conditions

  • Covid19
  • Pregnancy Related
  • Neonatal Infection

Sponsors & Collaborators

  • Fundacion Infant

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-10
Primary Completion
2020-10-01
Completion
2020-10-01

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04362956 on ClinicalTrials.gov